查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1563916

全球细胞健康检测市场

Cellular Health Testing
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 184 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，全球细胞健康检测市场将达到 65 亿美元

全球细胞健康检测市场预计 2023 年为 37 亿美元，预计到 2030 年将达到 65 亿美元，2023-2030 年分析期间复合年增长率为 8.4%。单一测试面板是本报告分析的细分市场之一，预计复合年增长率为 7.3%，到分析期结束时将达到 37 亿美元。在分析期间，多重测试面板细分市场的复合年增长率预计为 10.2%。

美国市场预计将成长9.78亿美元，中国复合年增长率为8.0%

预计 2023 年美国细胞健康检测市场规模将达 9.78 亿美元。中国作为世界第二大经济体，预计到 2030 年市场规模将达到 10 亿美元，2023-2030 年分析期间复合年增长率为 8.0%。其他值得注意的区域市场包括日本和加拿大，在分析期间预计复合年增长率分别为 7.4% 和 7.1%。在欧洲，德国的复合年增长率预计约为 6.6%。

全球细胞健康检测市场－主要趋势与驱动因素总结

细胞健康测试将如何改变生物医学和临床研究？

细胞健康测试在生物医学和临床研究中发挥越来越重要的作用，可以更深入地了解细胞的功能、对治疗的反应和年龄。这些测试评估各种细胞功能，例如能量产生、氧化压力水平和 DNA 损伤，从而全面了解细胞活力和活力。细胞健康测试广泛应用于细胞功能对疾病进展至关重要的研究领域，例如肿瘤学、代谢疾病和老化。例如，在癌症研究中，检查癌细胞的健康状况可以帮助确定癌细胞对治疗的反应，并指南开发更有针对性的治疗方法。同样，在代谢疾病研究中，细胞健康测试用于监测粒线体功能，提供有关细胞如何产生和管理能量的重要资讯。随着医疗保健转向预防性护理和早期疗育，细胞健康测试正在成为在潜在问题表现为症状之前识别它们的宝贵工具。

为什么细胞健康检测对于药物开发和疾病管理很重要？

细胞健康测试对于药物开发和疾病管理至关重要，因为它使研究人员和临床医生能够评估细胞对各种治疗性介入、压力源和环境因素的反应。在药物开发中，这些测试用于评估药物是否增强或损害细胞功能，从而儘早了解其治疗潜力和毒性。评估 ATP 产生、活性氧 (ROS) 产生和细胞凋亡等指标的细胞健康检测可以帮助确定化合物是否支持健康的细胞功能或诱导细胞死亡。这在肿瘤学中尤其重要，药物用于选择性杀死癌细胞，同时保留健康细胞。在慢性病管理中，细胞健康测试可透过追踪细胞代谢、发炎和 DNA 完整性的变化来监测疾病进展。例如，粒线体健康测试用于了解帕金森氏症和阿兹海默症症等神经退化性疾病中细胞能量产生如何随着时间的推移而下降，为潜在的治疗性介入提供目标。随着医疗保健朝着更个人化的方向发展，细胞健康测试对于监测个人对治疗的反应和管理长期健康状况仍然至关重要。

科技创新如何增强细胞健康测试？

技术进步显着提高了细胞健康测试的准确性和范围，使研究人员能够获得有关细胞功能的更详细和动态的资料。一项重大突破是即时成像和活细胞分析技术的使用。这使得人们更了解细胞在不同条件下的行为，例如药物暴露和氧化压力，从而提供更完整的细胞反应整体情况。高通量筛检平台也彻底改变了这个领域，使实验室能够同时对数千个样本进行细胞健康测试。这些进步在药物发现中特别有价值，快速、大规模的测试对于识别有前景的候选治疗药物至关重要。此外，代谢体学和单细胞分析技术的进步透过测量代谢变化和评估群体内单一细胞的健康状况提供了更详细的细胞健康资料。随着 3D 细胞培养和器官晶片技术的兴起，细胞健康测试对于复杂组织和器官的建模也变得越来越重要，从而可以在更生理相关的环境中研究细胞行为。这些创新正在突破细胞健康测试的极限，带来更准确、更可行的见解。

细胞健康检测市场的成长要素有哪些？

细胞健康检测市场的成长受到多种因素的推动，包括对个人化医疗的需求不断增加、对预防医学的兴趣日益增长以及检测技术的进步。关键驱动因素之一是人们越来越认识到细胞健康是整体健康和疾病风险的重要指标，从而导致在研究和临床环境中更多地采用这些测试。随着医疗保健转向更个人化的方法，细胞健康测试正在成为个人化医疗的基石，帮助医生和研究人员了解患者的细胞功能和对治疗的反应，这有助于我在更个人的层面上了解人们。即时细胞分析、高通量测试平台和先进成像技术等技术创新使细胞健康测试变得更加容易和高效，促进其在药物发现和药物开发中的使用。糖尿病、心血管疾病和神经退化性疾病等慢性疾病的盛行率不断上升也促进了市场的成长，因为这些疾病往往伴随着细胞功能受损。此外，消费者对健康和长寿的兴趣导致对细胞健康测试的需求增加，作为监测老化和製定改善长期健康策略的工具。由于生命科学研究投资的增加、临床诊断应用的扩大以及细胞健康测试在治疗开发中的广泛使用，预计未来几年细胞健康测试市场将强劲成长。

受访企业范例（共22例）

  • Bio-Reference Laboratories, Inc.
  • Cell Science Systems Corp.
  • Cleveland Heartlab, Inc.
  • Dna Labs India
  • Genova Diagnostics
  • Immundiagnostik AG
  • Laboratory Corporation of America Holdings
  • Life Length
  • Quest Diagnostics, Inc.
  • Repeat Diagnostics Inc.（Repeat Dx）
  • Segterra, Inc.
  • SpectraCell Laboratories, Inc.
  • Telomere Diagnostics, Inc.（Tdx）
  • Zimetry LLC

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 其他领域

第四章 比赛

简介目录
Product Code: MCP10955

Global Cellular Health Testing Market to Reach US$6.5 Billion by 2030

The global market for Cellular Health Testing estimated at US$3.7 Billion in the year 2023, is expected to reach US$6.5 Billion by 2030, growing at a CAGR of 8.4% over the analysis period 2023-2030. Single-test Panels, one of the segments analyzed in the report, is expected to record a 7.3% CAGR and reach US$3.7 Billion by the end of the analysis period. Growth in the Multi-test Panels segment is estimated at 10.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$978.0 Million While China is Forecast to Grow at 8.0% CAGR

The Cellular Health Testing market in the U.S. is estimated at US$978.0 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$1.0 Billion by the year 2030 trailing a CAGR of 8.0% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.4% and 7.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.6% CAGR.

Global Cellular Health Testing Market - Key Trends and Drivers Summarized

How Is Cellular Health Testing Transforming Biomedical and Clinical Research?

Cellular health testing is playing an increasingly critical role in biomedical and clinical research, offering deeper insights into how cells function, respond to treatments, and age. These tests assess various cellular functions, such as energy production, oxidative stress levels, and DNA damage, providing a comprehensive understanding of cell viability and vitality. Cellular health testing is widely used in research areas like oncology, metabolic disorders, and aging, where cellular function is central to disease progression. In cancer research, for instance, testing the health of tumor cells can help determine how they respond to treatments, guiding the development of more targeted therapies. Similarly, in the study of metabolic diseases, cellular health tests are used to monitor mitochondrial function, providing crucial information on how cells produce and manage energy. As the focus in medicine shifts toward preventative care and early intervention, cellular health testing is becoming a valuable tool for identifying underlying issues before they manifest as symptoms, leading to better outcomes for patients and more personalized approaches to healthcare.

Why Is Cellular Health Testing Critical in Drug Development and Disease Management?

Cellular health testing is essential for drug development and disease management because it allows researchers and clinicians to evaluate how cells respond to different therapeutic interventions, stressors, and environmental factors. In drug development, these tests are used to assess whether a drug enhances or impairs cellular function, offering early insights into its therapeutic potential or toxicity. Cellular health assays, which evaluate metrics like ATP production, reactive oxygen species (ROS) generation, and apoptosis, help determine whether a compound supports healthy cell function or triggers cell death. This is particularly important in oncology, where drugs aim to selectively kill cancer cells while sparing healthy ones. In chronic disease management, cellular health testing can be used to monitor disease progression by tracking changes in cellular metabolism, inflammation, or DNA integrity. For example, mitochondrial health tests are used in neurodegenerative diseases like Parkinson’s and Alzheimer’s to understand how cellular energy production declines over time, providing targets for potential therapeutic interventions. As healthcare moves towards more personalized approaches, cellular health testing will continue to be vital for monitoring individual responses to treatments and managing long-term health conditions.

How Are Technological Innovations Enhancing Cellular Health Testing?

Technological advancements are significantly enhancing the precision and scope of cellular health testing, enabling researchers to capture more detailed and dynamic data on cell function. One major breakthrough is the use of real-time imaging and live-cell analysis technologies, which allow scientists to monitor cellular health continuously over time without disrupting the cells. This has led to a better understanding of how cells behave under different conditions, such as drug exposure or oxidative stress, offering a more complete picture of cellular responses. High-throughput screening platforms have also revolutionized the field, enabling laboratories to conduct cellular health tests on thousands of samples simultaneously. These advancements are particularly valuable in drug discovery, where rapid, large-scale testing is essential for identifying promising therapeutic candidates. Additionally, advances in metabolomics and single-cell analysis technologies are providing more granular data on cellular health by measuring metabolic changes and assessing the health of individual cells within a population. With the rise of 3D cell cultures and organ-on-a-chip technologies, cellular health testing is also becoming more relevant for modeling complex tissues and organs, making it possible to study cell behavior in more physiologically relevant environments. These innovations are pushing the boundaries of what is possible in cellular health testing, leading to more accurate and actionable insights.

What Are the Key Factors Growth in the Cellular Health Testing Market?

The growth in the cellular health testing market is driven by several factors, including the rising demand for personalized medicine, the increasing focus on preventative healthcare, and advancements in testing technologies. One of the key drivers is the growing recognition that cellular health is a critical indicator of overall health and disease risk, which has led to greater adoption of these tests in both research and clinical settings. As healthcare shifts towards more individualized approaches, cellular health testing is becoming a cornerstone of personalized medicine, helping doctors and researchers understand how a patient’s cells function and respond to treatments on a more personal level. Technological innovations, such as real-time cell analysis, high-throughput testing platforms, and advanced imaging techniques, are making cellular health testing more accessible and efficient, driving its use in drug discovery and development. The rising prevalence of chronic diseases like diabetes, cardiovascular conditions, and neurodegenerative disorders is also contributing to market growth, as these conditions often involve disruptions in cellular function. Moreover, consumer interest in wellness and longevity has led to a growing demand for cellular health testing as a tool for monitoring aging and developing strategies to improve long-term health. With increasing investment in life sciences research, expanding applications in clinical diagnostics, and the growing use of cellular health tests in therapeutic development, the market for cellular health testing is expected to experience robust growth in the coming years.

Select Competitors (Total 22 Featured) -

  • Bio-Reference Laboratories, Inc.
  • Cell Science Systems Corp.
  • Cleveland Heartlab, Inc.
  • Dna Labs India
  • Genova Diagnostics
  • Immundiagnostik AG
  • Laboratory Corporation of America Holdings
  • Life Length
  • Quest Diagnostics, Inc.
  • Repeat Diagnostics Inc. (Repeat Dx)
  • Segterra, Inc.
  • SpectraCell Laboratories, Inc.
  • Telomere Diagnostics, Inc. (Tdx)
  • Zimetry LLC

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Global Economic Update
    • Cellular Health Testing - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Awareness of Preventive Healthcare Propels Growth in Cellular Health Testing Market
    • Advancements in Biomarker Discovery Expand Addressable Market Opportunity for Cellular Health Diagnostics
    • Increasing Focus on Longevity and Aging Research Strengthens Business Case for Cellular Health Testing
    • Innovations in Genomic and Proteomic Testing Spur Growth in Cellular Health Assessments
    • Rising Interest in Nutritional Genomics and Lifestyle Medicine Accelerates Demand for Cellular Health Monitoring
    • Increasing Use of Cellular Health Testing in Chronic Disease Management Sustains Market Growth
    • Shift Towards Home-Based and Remote Health Monitoring Expands Market Accessibility for Cellular Health Tests
    • Advances in Mitochondrial Function Testing Throw the Spotlight on Cellular Energy and Health Diagnostics
    • Increasing Adoption of Cellular Health Testing in Functional Medicine Practices Spurs Market Expansion
    • Growing Investments in Biotechnology and Diagnostics Drive Innovation and New Product Development in Cellular Health Testing
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Cellular Health Testing Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Cellular Health Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Cellular Health Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Cellular Health Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Single-test Panels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Single-test Panels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Single-test Panels by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Multi-test Panels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Multi-test Panels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Multi-test Panels by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Blood Samples by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Blood Samples by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Blood Samples by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other Sample Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Other Sample Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Other Sample Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for At-home by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for At-home by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for At-home by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for In-office by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for In-office by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for In-office by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Other Collection Sites by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Other Collection Sites by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Other Collection Sites by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Cellular Health Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Cellular Health Testing by Type - Percentage Breakdown of Value Sales for Single-test Panels and Multi-test Panels for the Years 2014, 2024 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Cellular Health Testing by Sample Type - Blood Samples and Other Sample Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Cellular Health Testing by Sample Type - Blood Samples and Other Sample Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Cellular Health Testing by Sample Type - Percentage Breakdown of Value Sales for Blood Samples and Other Sample Types for the Years 2014, 2024 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Cellular Health Testing by Collection Site - At-home, In-office and Other Collection Sites - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Cellular Health Testing by Collection Site - At-home, In-office and Other Collection Sites Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Cellular Health Testing by Collection Site - Percentage Breakdown of Value Sales for At-home, In-office and Other Collection Sites for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Canada 16-Year Perspective for Cellular Health Testing by Type - Percentage Breakdown of Value Sales for Single-test Panels and Multi-test Panels for the Years 2014, 2024 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Cellular Health Testing by Sample Type - Blood Samples and Other Sample Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Cellular Health Testing by Sample Type - Blood Samples and Other Sample Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Canada 16-Year Perspective for Cellular Health Testing by Sample Type - Percentage Breakdown of Value Sales for Blood Samples and Other Sample Types for the Years 2014, 2024 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Cellular Health Testing by Collection Site - At-home, In-office and Other Collection Sites - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Cellular Health Testing by Collection Site - At-home, In-office and Other Collection Sites Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Canada 16-Year Perspective for Cellular Health Testing by Collection Site - Percentage Breakdown of Value Sales for At-home, In-office and Other Collection Sites for the Years 2014, 2024 & 2030
  • JAPAN
    • Cellular Health Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Japan 16-Year Perspective for Cellular Health Testing by Type - Percentage Breakdown of Value Sales for Single-test Panels and Multi-test Panels for the Years 2014, 2024 & 2030
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Cellular Health Testing by Sample Type - Blood Samples and Other Sample Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Cellular Health Testing by Sample Type - Blood Samples and Other Sample Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Japan 16-Year Perspective for Cellular Health Testing by Sample Type - Percentage Breakdown of Value Sales for Blood Samples and Other Sample Types for the Years 2014, 2024 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Cellular Health Testing by Collection Site - At-home, In-office and Other Collection Sites - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Cellular Health Testing by Collection Site - At-home, In-office and Other Collection Sites Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Japan 16-Year Perspective for Cellular Health Testing by Collection Site - Percentage Breakdown of Value Sales for At-home, In-office and Other Collection Sites for the Years 2014, 2024 & 2030
  • CHINA
    • Cellular Health Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 53: China Recent Past, Current & Future Analysis for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: China Historic Review for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: China 16-Year Perspective for Cellular Health Testing by Type - Percentage Breakdown of Value Sales for Single-test Panels and Multi-test Panels for the Years 2014, 2024 & 2030
    • TABLE 56: China Recent Past, Current & Future Analysis for Cellular Health Testing by Sample Type - Blood Samples and Other Sample Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Cellular Health Testing by Sample Type - Blood Samples and Other Sample Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: China 16-Year Perspective for Cellular Health Testing by Sample Type - Percentage Breakdown of Value Sales for Blood Samples and Other Sample Types for the Years 2014, 2024 & 2030
    • TABLE 59: China Recent Past, Current & Future Analysis for Cellular Health Testing by Collection Site - At-home, In-office and Other Collection Sites - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Cellular Health Testing by Collection Site - At-home, In-office and Other Collection Sites Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: China 16-Year Perspective for Cellular Health Testing by Collection Site - Percentage Breakdown of Value Sales for At-home, In-office and Other Collection Sites for the Years 2014, 2024 & 2030
  • EUROPE
    • Cellular Health Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Cellular Health Testing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Cellular Health Testing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Europe 16-Year Perspective for Cellular Health Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Europe 16-Year Perspective for Cellular Health Testing by Type - Percentage Breakdown of Value Sales for Single-test Panels and Multi-test Panels for the Years 2014, 2024 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Cellular Health Testing by Sample Type - Blood Samples and Other Sample Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Cellular Health Testing by Sample Type - Blood Samples and Other Sample Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Europe 16-Year Perspective for Cellular Health Testing by Sample Type - Percentage Breakdown of Value Sales for Blood Samples and Other Sample Types for the Years 2014, 2024 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Cellular Health Testing by Collection Site - At-home, In-office and Other Collection Sites - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Cellular Health Testing by Collection Site - At-home, In-office and Other Collection Sites Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Europe 16-Year Perspective for Cellular Health Testing by Collection Site - Percentage Breakdown of Value Sales for At-home, In-office and Other Collection Sites for the Years 2014, 2024 & 2030
  • FRANCE
    • Cellular Health Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 74: France Recent Past, Current & Future Analysis for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: France Historic Review for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: France 16-Year Perspective for Cellular Health Testing by Type - Percentage Breakdown of Value Sales for Single-test Panels and Multi-test Panels for the Years 2014, 2024 & 2030
    • TABLE 77: France Recent Past, Current & Future Analysis for Cellular Health Testing by Sample Type - Blood Samples and Other Sample Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: France Historic Review for Cellular Health Testing by Sample Type - Blood Samples and Other Sample Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: France 16-Year Perspective for Cellular Health Testing by Sample Type - Percentage Breakdown of Value Sales for Blood Samples and Other Sample Types for the Years 2014, 2024 & 2030
    • TABLE 80: France Recent Past, Current & Future Analysis for Cellular Health Testing by Collection Site - At-home, In-office and Other Collection Sites - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Cellular Health Testing by Collection Site - At-home, In-office and Other Collection Sites Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: France 16-Year Perspective for Cellular Health Testing by Collection Site - Percentage Breakdown of Value Sales for At-home, In-office and Other Collection Sites for the Years 2014, 2024 & 2030
  • GERMANY
    • Cellular Health Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 83: Germany Recent Past, Current & Future Analysis for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Germany Historic Review for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Germany 16-Year Perspective for Cellular Health Testing by Type - Percentage Breakdown of Value Sales for Single-test Panels and Multi-test Panels for the Years 2014, 2024 & 2030
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Cellular Health Testing by Sample Type - Blood Samples and Other Sample Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Germany Historic Review for Cellular Health Testing by Sample Type - Blood Samples and Other Sample Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Germany 16-Year Perspective for Cellular Health Testing by Sample Type - Percentage Breakdown of Value Sales for Blood Samples and Other Sample Types for the Years 2014, 2024 & 2030
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Cellular Health Testing by Collection Site - At-home, In-office and Other Collection Sites - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Cellular Health Testing by Collection Site - At-home, In-office and Other Collection Sites Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Germany 16-Year Perspective for Cellular Health Testing by Collection Site - Percentage Breakdown of Value Sales for At-home, In-office and Other Collection Sites for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 92: Italy Recent Past, Current & Future Analysis for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Italy Historic Review for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Italy 16-Year Perspective for Cellular Health Testing by Type - Percentage Breakdown of Value Sales for Single-test Panels and Multi-test Panels for the Years 2014, 2024 & 2030
    • TABLE 95: Italy Recent Past, Current & Future Analysis for Cellular Health Testing by Sample Type - Blood Samples and Other Sample Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Italy Historic Review for Cellular Health Testing by Sample Type - Blood Samples and Other Sample Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Italy 16-Year Perspective for Cellular Health Testing by Sample Type - Percentage Breakdown of Value Sales for Blood Samples and Other Sample Types for the Years 2014, 2024 & 2030
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Cellular Health Testing by Collection Site - At-home, In-office and Other Collection Sites - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for Cellular Health Testing by Collection Site - At-home, In-office and Other Collection Sites Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Italy 16-Year Perspective for Cellular Health Testing by Collection Site - Percentage Breakdown of Value Sales for At-home, In-office and Other Collection Sites for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Cellular Health Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 101: UK Recent Past, Current & Future Analysis for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: UK Historic Review for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: UK 16-Year Perspective for Cellular Health Testing by Type - Percentage Breakdown of Value Sales for Single-test Panels and Multi-test Panels for the Years 2014, 2024 & 2030
    • TABLE 104: UK Recent Past, Current & Future Analysis for Cellular Health Testing by Sample Type - Blood Samples and Other Sample Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: UK Historic Review for Cellular Health Testing by Sample Type - Blood Samples and Other Sample Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: UK 16-Year Perspective for Cellular Health Testing by Sample Type - Percentage Breakdown of Value Sales for Blood Samples and Other Sample Types for the Years 2014, 2024 & 2030
    • TABLE 107: UK Recent Past, Current & Future Analysis for Cellular Health Testing by Collection Site - At-home, In-office and Other Collection Sites - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: UK Historic Review for Cellular Health Testing by Collection Site - At-home, In-office and Other Collection Sites Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: UK 16-Year Perspective for Cellular Health Testing by Collection Site - Percentage Breakdown of Value Sales for At-home, In-office and Other Collection Sites for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 110: Rest of Europe Recent Past, Current & Future Analysis for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Rest of Europe Historic Review for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: Rest of Europe 16-Year Perspective for Cellular Health Testing by Type - Percentage Breakdown of Value Sales for Single-test Panels and Multi-test Panels for the Years 2014, 2024 & 2030
    • TABLE 113: Rest of Europe Recent Past, Current & Future Analysis for Cellular Health Testing by Sample Type - Blood Samples and Other Sample Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Rest of Europe Historic Review for Cellular Health Testing by Sample Type - Blood Samples and Other Sample Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: Rest of Europe 16-Year Perspective for Cellular Health Testing by Sample Type - Percentage Breakdown of Value Sales for Blood Samples and Other Sample Types for the Years 2014, 2024 & 2030
    • TABLE 116: Rest of Europe Recent Past, Current & Future Analysis for Cellular Health Testing by Collection Site - At-home, In-office and Other Collection Sites - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: Rest of Europe Historic Review for Cellular Health Testing by Collection Site - At-home, In-office and Other Collection Sites Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: Rest of Europe 16-Year Perspective for Cellular Health Testing by Collection Site - Percentage Breakdown of Value Sales for At-home, In-office and Other Collection Sites for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Cellular Health Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 119: Asia-Pacific Recent Past, Current & Future Analysis for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: Asia-Pacific Historic Review for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: Asia-Pacific 16-Year Perspective for Cellular Health Testing by Type - Percentage Breakdown of Value Sales for Single-test Panels and Multi-test Panels for the Years 2014, 2024 & 2030
    • TABLE 122: Asia-Pacific Recent Past, Current & Future Analysis for Cellular Health Testing by Sample Type - Blood Samples and Other Sample Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Asia-Pacific Historic Review for Cellular Health Testing by Sample Type - Blood Samples and Other Sample Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: Asia-Pacific 16-Year Perspective for Cellular Health Testing by Sample Type - Percentage Breakdown of Value Sales for Blood Samples and Other Sample Types for the Years 2014, 2024 & 2030
    • TABLE 125: Asia-Pacific Recent Past, Current & Future Analysis for Cellular Health Testing by Collection Site - At-home, In-office and Other Collection Sites - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Asia-Pacific Historic Review for Cellular Health Testing by Collection Site - At-home, In-office and Other Collection Sites Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: Asia-Pacific 16-Year Perspective for Cellular Health Testing by Collection Site - Percentage Breakdown of Value Sales for At-home, In-office and Other Collection Sites for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 128: Rest of World Recent Past, Current & Future Analysis for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Rest of World Historic Review for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: Rest of World 16-Year Perspective for Cellular Health Testing by Type - Percentage Breakdown of Value Sales for Single-test Panels and Multi-test Panels for the Years 2014, 2024 & 2030
    • TABLE 131: Rest of World Recent Past, Current & Future Analysis for Cellular Health Testing by Sample Type - Blood Samples and Other Sample Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Rest of World Historic Review for Cellular Health Testing by Sample Type - Blood Samples and Other Sample Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: Rest of World 16-Year Perspective for Cellular Health Testing by Sample Type - Percentage Breakdown of Value Sales for Blood Samples and Other Sample Types for the Years 2014, 2024 & 2030
    • TABLE 134: Rest of World Recent Past, Current & Future Analysis for Cellular Health Testing by Collection Site - At-home, In-office and Other Collection Sites - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Rest of World Historic Review for Cellular Health Testing by Collection Site - At-home, In-office and Other Collection Sites Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: Rest of World 16-Year Perspective for Cellular Health Testing by Collection Site - Percentage Breakdown of Value Sales for At-home, In-office and Other Collection Sites for the Years 2014, 2024 & 2030

IV. COMPETITION